TULP2
gene geneOn this page
Also known as TUBL2CT65
Summary
TULP2 (TUB like protein 2, HGNC:12424) is a protein-coding gene on chromosome 19q13.33, encoding Tubby-related protein 2 (O00295).
TULP2 is a member of a family of tubby-like genes (TULPs) that encode proteins of unknown function. Members of this family have been identified in plants, vertebrates, and invertebrates. The TULP proteins share a conserved C-terminal region of approximately 200 amino acid residues.
Source: NCBI Gene 7288 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 95 total
- MANE Select transcript:
NM_003323
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12424 |
| Approved symbol | TULP2 |
| Name | TUB like protein 2 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TUBL2, CT65 |
| Ensembl gene | ENSG00000104804 |
| Ensembl biotype | protein_coding |
| OMIM | 602309 |
| Entrez | 7288 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000221399, ENST00000518572, ENST00000520977, ENST00000522229, ENST00000522945, ENST00000706741, ENST00000706742, ENST00000706743, ENST00000706744
RefSeq mRNA: 1 — MANE Select: NM_003323
NM_003323
CCDS: CCDS12739
Canonical transcript exons
ENST00000221399 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000718395 | 48889510 | 48889631 |
| ENSE00000718402 | 48894998 | 48895162 |
| ENSE00000718409 | 48895366 | 48895503 |
| ENSE00000853369 | 48896430 | 48896556 |
| ENSE00000853370 | 48897345 | 48897396 |
| ENSE00000853371 | 48897837 | 48897869 |
| ENSE00001342189 | 48898590 | 48898744 |
| ENSE00002501941 | 48887950 | 48888261 |
| ENSE00003996821 | 48880967 | 48881126 |
| ENSE00003996823 | 48885448 | 48885560 |
| ENSE00003996829 | 48882032 | 48882203 |
| ENSE00003996832 | 48883754 | 48883852 |
| ENSE00003996833 | 48883932 | 48884046 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 95.82.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0115 / max 10.3750, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181953 | 0.0074 | 3 |
| 181952 | 0.0041 | 3 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 95.82 | gold quality |
| male germ cell | CL:0000015 | 93.31 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.93 | gold quality |
| right testis | UBERON:0004534 | 89.92 | gold quality |
| left testis | UBERON:0004533 | 89.85 | gold quality |
| testis | UBERON:0000473 | 87.19 | gold quality |
| granulocyte | CL:0000094 | 82.08 | gold quality |
| mucosa of stomach | UBERON:0001199 | 79.70 | gold quality |
| adult organism | UBERON:0007023 | 77.20 | gold quality |
| bone marrow cell | CL:0002092 | 74.04 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.20 | gold quality |
| right ovary | UBERON:0002118 | 63.85 | gold quality |
| spleen | UBERON:0002106 | 63.50 | gold quality |
| left uterine tube | UBERON:0001303 | 63.14 | gold quality |
| left ovary | UBERON:0002119 | 62.60 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 62.47 | gold quality |
| right frontal lobe | UBERON:0002810 | 62.43 | gold quality |
| lower esophagus | UBERON:0013473 | 62.39 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 62.18 | gold quality |
| prefrontal cortex | UBERON:0000451 | 61.71 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.44 | gold quality |
| cingulate cortex | UBERON:0003027 | 59.88 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 59.60 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 59.58 | gold quality |
| gall bladder | UBERON:0002110 | 59.38 | gold quality |
| ovary | UBERON:0000992 | 59.07 | gold quality |
| body of uterus | UBERON:0009853 | 58.83 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 58.29 | gold quality |
| frontal cortex | UBERON:0001870 | 58.17 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 58.13 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.00 |
| E-CURD-10 | no | 37.13 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-220f10.4 | ENSDARG00000062902 |
| mus_musculus | Tulp2 | ENSMUSG00000023467 |
| rattus_norvegicus | Tulp2 | ENSRNOG00000020927 |
| drosophila_melanogaster | ktub | FBGN0015721 |
Paralogs (5): TULP3 (ENSG00000078246), TULP1 (ENSG00000112041), WDR35 (ENSG00000118965), TULP4 (ENSG00000130338), TUB (ENSG00000166402)
Protein
Protein identifiers
Tubby-related protein 2 — O00295 (reviewed: O00295)
Alternative names: Cancer/testis antigen 65, Tubby-like protein 2
All UniProt accessions (6): A0A9L9PX91, A0A9L9PXV8, E5RH05, E5RHR0, E5RIF7, O00295
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. Secreted.
Tissue specificity. Strongly expressed in testis. Also expressed in retina. Expressed in cancer cell lines.
Similarity. Belongs to the TUB family.
RefSeq proteins (1): NP_003314* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000007 | Tubby_C | Domain |
| IPR005398 | Tubby_N | Domain |
| IPR018066 | Tubby_C_CS | Conserved_site |
| IPR025659 | Tubby-like_C | Homologous_superfamily |
Pfam: PF01167, PF16322
UniProt features (12 total): sequence variant 5, compositionally biased region 2, modified residue 2, chain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O00295-F1 | 67.08 | 0.33 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 135, 190
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 86 (showing top):
RNGTGGGC_UNKNOWN, GOBP_PROTEIN_LOCALIZATION_TO_CILIUM, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, MODULE_99, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_SENSORY_PERCEPTION, WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN, GOCC_CILIUM, WEBER_METHYLATED_HCP_IN_SPERM_DN, MODULE_248, SWEET_LUNG_CANCER_KRAS_UP, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MODULE_129, PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN, PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN
GO Biological Process (2): visual perception (GO:0007601), protein localization to cilium (GO:0061512)
GO Molecular Function (1): protein-containing complex binding (GO:0044877)
GO Cellular Component (3): extracellular region (GO:0005576), cytoplasm (GO:0005737), cilium (GO:0005929)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| sensory perception of light stimulus | 1 |
| protein localization to organelle | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
650 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TULP2 | SPATA31G1 | Q5VYM1 | 627 |
| TULP2 | REDIC1 | Q86WS4 | 595 |
| TULP2 | C9orf43 | Q8TAL5 | 575 |
| TULP2 | GARIN2 | Q8N9W8 | 565 |
| TULP2 | FAM209A | Q5JX71 | 564 |
| TULP2 | MAGEB16 | A2A368 | 532 |
| TULP2 | TMCO5A | Q8N6Q1 | 507 |
| TULP2 | TTC21B | Q7Z4L5 | 501 |
| TULP2 | TTC9B | Q8N6N2 | 498 |
| TULP2 | ZFAND4 | Q86XD8 | 497 |
| TULP2 | WBP2NL | Q6ICG8 | 490 |
| TULP2 | IRGQ | Q8WZA9 | 486 |
| TULP2 | PKDREJ | Q9NTG1 | 480 |
| TULP2 | EPPIN | O95925 | 478 |
| TULP2 | RAB23 | Q9ULC3 | 470 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TULP2 | LONP1 | psi-mi:“MI:0914”(association) | 0.530 |
| SRPK1 | TULP2 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| EWSR1 | TULP2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MEOX2 | TULP2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TULP2 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.350 |
| TULP2 | DDAH2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (62): TULP2 (Two-hybrid), TULP2 (Two-hybrid), TULP2 (Two-hybrid), CTR9 (Affinity Capture-MS), HDAC6 (Affinity Capture-MS), PAF1 (Affinity Capture-MS), LEO1 (Affinity Capture-MS), ZSWIM8 (Affinity Capture-MS), MAPK8IP2 (Affinity Capture-MS), IFT122 (Affinity Capture-MS), WDR19 (Affinity Capture-MS), SIK2 (Affinity Capture-MS), IFT140 (Affinity Capture-MS), CDC73 (Affinity Capture-MS), WDR35 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PPD8, A2A3K4, A4Q9E5, A4Q9F0, A4Q9F1, A6PVC2, A7E379, B2GUB3, D3YWQ0, F1MAB7, O00295, O15021, O75912, O89084, O94953, O94966, P03177, P15304, P46686, P54748, Q08493, Q0P4M4, Q14999, Q1ECV4, Q1HVD1, Q28969, Q3KSQ2, Q3ULB5, Q4G017, Q5R8Z4, Q5R978, Q5RCJ3, Q5TKR9, Q6EEF3, Q6EMB2, Q6J1Y9, Q6NZK8, Q6X4W1, Q6ZT98, Q7TNN8
Diamond homologs: A8WN62, B0WI30, B0XFQ9, B3MDU3, B3NJY0, B4H4X0, B4I7J9, B4J6R7, B4KNA9, B4LMR9, B4MKC7, B4P9H8, B4QFM2, O00294, O00295, O75386, O88413, O88808, P46686, P50586, P50607, Q09306, Q0WPY0, Q10LG8, Q16IR1, Q16KI5, Q28X18, Q2QXB2, Q53PP5, Q5QM27, Q688Y7, Q68Y48, Q69U54, Q6NPQ1, Q6Z2G9, Q75HX5, Q7PZK5, Q7XSV4, Q86PC9, Q8GVE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
95 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 78 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2194 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:48883973:T:TA | donor_gain | 1.0000 |
| 19:48884053:C:CT | acceptor_gain | 1.0000 |
| 19:48884054:A:T | acceptor_gain | 1.0000 |
| 19:48884063:A:AC | acceptor_gain | 1.0000 |
| 19:48885559:CG:C | acceptor_gain | 1.0000 |
| 19:48885561:C:CC | acceptor_gain | 1.0000 |
| 19:48887943:A:AC | donor_gain | 1.0000 |
| 19:48887944:C:CC | donor_gain | 1.0000 |
| 19:48887944:CTGCA:C | donor_gain | 1.0000 |
| 19:48889504:TCCTA:T | donor_loss | 1.0000 |
| 19:48889505:CCTAC:C | donor_loss | 1.0000 |
| 19:48889506:CTA:C | donor_loss | 1.0000 |
| 19:48889507:TAC:T | donor_loss | 1.0000 |
| 19:48889508:A:AG | donor_loss | 1.0000 |
| 19:48889628:GTCC:G | acceptor_gain | 1.0000 |
| 19:48889629:TCC:T | acceptor_gain | 1.0000 |
| 19:48889630:CC:C | acceptor_gain | 1.0000 |
| 19:48889630:CCC:C | acceptor_gain | 1.0000 |
| 19:48889631:CC:C | acceptor_gain | 1.0000 |
| 19:48889632:C:A | acceptor_loss | 1.0000 |
| 19:48889632:C:CC | acceptor_gain | 1.0000 |
| 19:48889635:A:AC | acceptor_gain | 1.0000 |
| 19:48889635:A:C | acceptor_gain | 1.0000 |
| 19:48889637:G:GC | acceptor_gain | 1.0000 |
| 19:48896595:C:CT | acceptor_gain | 1.0000 |
| 19:48882012:A:C | donor_gain | 0.9900 |
| 19:48882030:A:AC | donor_gain | 0.9900 |
| 19:48882031:C:CC | donor_gain | 0.9900 |
| 19:48882204:C:CA | acceptor_loss | 0.9900 |
| 19:48882204:C:CC | acceptor_gain | 0.9900 |
AlphaMissense
3414 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:48881080:G:C | F498L | 0.983 |
| 19:48881080:G:T | F498L | 0.983 |
| 19:48881082:A:G | F498L | 0.983 |
| 19:48881104:G:C | F490L | 0.980 |
| 19:48881104:G:T | F490L | 0.980 |
| 19:48881106:A:G | F490L | 0.980 |
| 19:48884022:G:C | F362L | 0.980 |
| 19:48884022:G:T | F362L | 0.980 |
| 19:48884024:A:G | F362L | 0.980 |
| 19:48882054:G:C | F475L | 0.977 |
| 19:48882054:G:T | F475L | 0.977 |
| 19:48882056:A:G | F475L | 0.977 |
| 19:48882057:G:C | N474K | 0.971 |
| 19:48882057:G:T | N474K | 0.971 |
| 19:48881053:G:C | S507R | 0.964 |
| 19:48881053:G:T | S507R | 0.964 |
| 19:48881055:T:G | S507R | 0.964 |
| 19:48881035:G:C | S513R | 0.963 |
| 19:48881035:G:T | S513R | 0.963 |
| 19:48881037:T:G | S513R | 0.963 |
| 19:48881038:G:C | F512L | 0.961 |
| 19:48881038:G:T | F512L | 0.961 |
| 19:48881040:A:G | F512L | 0.961 |
| 19:48882090:G:C | F463L | 0.960 |
| 19:48882090:G:T | F463L | 0.960 |
| 19:48882092:A:G | F463L | 0.960 |
| 19:48882055:A:G | F475S | 0.956 |
| 19:48881068:G:C | F502L | 0.953 |
| 19:48881068:G:T | F502L | 0.953 |
| 19:48881070:A:G | F502L | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000028104 (19:48897360 C>A), RS1000113043 (19:48889569 T>C), RS1000307076 (19:48883724 A>G), RS1000446799 (19:48888349 C>T), RS1000618476 (19:48882215 A>G), RS1000674338 (19:48882793 C>T), RS1000678771 (19:48883538 C>T), RS1000857859 (19:48898791 G>A), RS1000892066 (19:48898978 A>C), RS1000923926 (19:48885929 G>A), RS1000991612 (19:48892506 T>G), RS1001189129 (19:48890895 G>C), RS1001396289 (19:48885042 A>G,T), RS1001472879 (19:48893906 G>A), RS1001575211 (19:48894720 T>A)
Disease associations
OMIM: gene MIM:602309 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| licochalcone B | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Methotrexate | decreases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.